加味半夏白术天麻汤联合循经刮痧治疗痰湿壅盛型高血压的疗效研究

卢咏红; 孙彦琴; 杨红蕾; 曹艳艳; 刘艳萍

doi:10.16766/j.cnki.issn.1674-4152.004413

加味半夏白术天麻汤联合循经刮痧治疗痰湿壅盛型高血压的疗效研究

doi: 10.16766/j.cnki.issn.1674-4152.004413

卢咏红^{1, 2},
孙彦琴^{1, 2, ,},
杨红蕾^{1, 2},
曹艳艳^{1, 2},
刘艳萍^{1, 2}

1.
河南中医药大学第一附属医院心脏中心，河南郑州 450000
2.
中西医防治重大疾病河南省协同创新中心，河南郑州 450046

基金项目:

河南省中医药科学研究专项课题 2023ZXZX1008

详细信息

通讯作者:
孙彦琴，E-mail：yfysyq@sina.com

中图分类号: R544.1 R289.51
计量
- 文章访问数: 13
- HTML全文浏览量: 6
- PDF下载量: 1
- 被引次数: 0
出版历程
- 收稿日期: 2024-08-06
- 网络出版日期: 2026-06-02

Study on the curative effect of added Banxia Baizhu Tianma Decoction combined with Meridian craping in the treatment of phlegm-dampness obstructing hypertension

LU Yonghong^{1, 2},
SUN Yanqin^{1, 2
, ,},
YANG Honglei^{1, 2},
CAO Yanyan^{1, 2},
LIU Yanping^{1, 2}

1.
Department of Cardiology, the First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan 450000, China

摘要

摘要: 目的探讨加味半夏白术天麻汤联合循经刮痧治疗痰湿壅盛型高血压的临床疗效及对血液黏度的影响，为高血压的临床治疗提供可靠的中西医结合方案。方法选择2024年1—5月河南中医药大学第一附属医院心脏中心收治的104例高血压患者，按照随机数字表法分为对照组(52例)和研究组(52例)。对照组给予氨氯地平治疗，研究组加用加味半夏白术天麻汤联合循经刮痧，6周后比较2组治疗效果、血压变化、中医证候积分、血液黏度以及不良反应的发生情况。结果研究组总有效率为90.38%(47/52)，高于对照组的73.08%(38/52)，χ²=4.300，P=0.038；治疗后2组收缩压、舒张压有所降低，且研究组低于对照组[(126.31±6.28)mmHg vs. (130.48±7.20)mmHg；(75.54±7.12)mmHg vs. (79.85±6.30)mmHg，P < 0.05，1 mmHg=0.133 kPa]；治疗后2组中医证候积分、红细胞聚集指数、血浆黏度较治疗前降低(P < 0.05)，且研究组低于对照组(P < 0.05)。结论联合应用加味半夏白术天麻汤和循经刮痧治疗高血压效果良好，可进一步降低血压，改善中医体质，调节血液黏度，安全性良好。
- 加味半夏白术天麻汤 /
- 循经刮痧 /
- 高血压 /
- 痰湿壅盛证 /
- 血液黏度
Abstract: Objective To investigate the clinical efficacy of supplemented Banxia Baizhu Tianma Decoction combined with Meridian craping in treating hypertension with phlegm-dampness obstructing and its influence on blood viscosity, and to provide a reliable integrated plan for the clinical treatment of hypertension. Methods A total of 104 hypertensive patients were admitted to the First Affiliated Hospital of Henan University of Chinese Medicine from January 2024 to May 2024. These patients were divided into a control group and a study group, with 52 patients assigned according to the random number table. The control group received amlodipine treatment, while the study group received a combination of supplemented Banxia Baizhu Tianma Decoction and Meridian scraping. Following a period of six weeks, a comparison was made of the therapeutic effect, blood pressure change, TCM syndrome score, blood viscosity and the occurrence of adverse reactions. Results The total effective rate of the study group was 90.38% (47/52), which was higher than that in the control group [73.08% (38/52), χ²=4.300, P=0.038]. After treatment, SBP and DBP in two groups were lower (P < 0.05), and the study group were lower than control group [(126.31±6.28) mmHg vs. (130.48±7.20) mmHg, (75.54±7.12) mmHg vs. (79.85±6.30) mmHg, P < 0.05, 1 mmHg=0.133 kPa]. After treatment, a reduction in TCM syndrome score, red blood cell aggregation index and plasma viscosity was observed in both groups (P < 0.05), and the study group were lower than control group (P < 0.05). Conclusion Supplemented Banxia Baizhu Tianma Decoction combined with Meridian scraping has a good effect on treating hypertension, which can further reduce blood pressure, improve TCM syndromes, regulate blood viscosity and have good safety.
- Supplemented Banxia Baizhu Tianma Decoction /
- Meridian scraping /
- High blood pressure /
- Excessive phlegm dampness /
- Blood viscosity

HTML全文

表 1 2组高血压患者一般资料比较

Table 1. Comparison of general information between two groups of hypertensive patients

组别	例数	性别(例)		年龄 (x±s，岁)	高血压分级[例(%)]		高血压病程 (x±s，年)
组别	例数	男性	女性	年龄 (x±s，岁)	Ⅰ级	Ⅱ级	高血压病程 (x±s，年)
研究组	52	27	25	57.64±9.33	24(46.15)	28(53.85)	6.47±1.04
对照组	52	29	23	58.41±8.79	21(40.38)	31(59.62)	6.75±1.21
统计量		0.155^a		0.433^b	0.353^c		1.265^b
P值		0.694		0.666	0.553		0.209
注：^a为χ²值，^b为t值，^c为Z值。

下载: 导出CSV

表 2 2组高血压患者总有效率比较[例(%)]

Table 2. Comparison of total effective rates between two groups of hypertensive patients [case (%)]

组别	例数	显效	有效	无效	总有效
研究组	52	19(36.54)	28(53.85)	5(9.62)	47(90.38)
对照组	52	13(25.00)	25(48.08)	14(26.92)	38(73.08)
注：2组总有效率比较，χ²=4.300，P=0.038。

下载: 导出CSV

表 3 2组高血压患者血压比较(x±s，mmHg)

Table 3. Comparison of blood pressure between two groups of hypertensive patients (x±s, mmHg)

组别	例数	SBP		DBP
组别	例数	治疗前	治疗后	治疗前	治疗后
研究组	52	161.33±9.52	126.31±6.28^b	100.75±5.21	75.54±7.12^b
对照组	52	160.74±10.13	130.48±7.20^b	101.36±4.88	79.85±6.30^b
统计量		0.306^a	-3.902^c	-0.616^a	-4.028^c
P值		0.760	< 0.001	0.539	< 0.001
注：^a为t值，^c为F值；与同组治疗前比较，^bP < 0.05。

下载: 导出CSV

表 4 2组高血压患者中医证候积分比较(x±s，分)

Table 4. Comparison of traditional chinese medicine syndrome points between two groups of hypertensive patients (x±s, points)

组别	例数	眩晕		头痛		头重如裹		胸脘痞闷		呕吐痰涎
组别	例数	治疗前	治疗后	治疗前	治疗后	治疗前	治疗后	治疗前	治疗后	治疗前	治疗后
研究组	52	4.37±0.72	1.58±0.49^b	4.42±0.63	1.41±0.35^b	4.28±0.80	1.53±0.46^b	3.95±0.93	1.63±0.54^b	3.75±1.12	1.46±0.43^b
对照组	52	4.51±0.65	2.04±0.63^b	4.37±0.74	1.98±0.55^b	4.36±0.68	2.11±0.57^b	4.04±0.87	2.07±0.62^b	3.85±0.96	1.92±0.59^b
统计量		-1.041^a	-3.461^c	0.371^a	-6.305^c	-0.549^a	-5.710^c	-0.510^a	-3.210^c	-0.244^a	-4.346^c
P值		0.300	0.001	0.711	< 0.001	0.584	< 0.001	0.611	0.002	0.807	< 0.001
注：^a为t值；^c为F值；与同组治疗前比较，^bP < 0.05。

下载: 导出CSV

表 5 2组高血压患者血液黏度比较(x±s)

Table 5. Comparison of blood viscosity between two groups of hypertensive patients (x±s)

组别	例数	红细胞聚集指数		血浆黏度(mPa·s)
组别	例数	治疗前	治疗后	治疗前	治疗后
研究组	52	2.48±0.71	1.68±0.42^b	2.03±0.34	1.44±0.32^b
对照组	52	2.53±0.65	1.96±0.55^b	1.99±0.40	1.62±0.43^b
统计量		-0.375^a	-3.945^c	0.549^a	-3.810^c
P值		0.709	0.004	0.584	0.017
注：^a为t值；^c为F值；与同组治疗前比较，^bP < 0.05。

下载: 导出CSV

参考文献(20)

[1]	张倩雲, 刘学春, 谈政, 等. 社区中老年高血压患者并发失眠高风险的现况及影响因素分析[J]. 安徽医学, 2024, 45(8): 1017-1021. ZHANG Q Y, LIU X C, TAN Z, et al. To analyze the high-risk status and influencing factors of insomnia in middle-aged and elderly patients with hypertension in community[J]. Anhui Medical Journal, 2024, 45(8): 1017-1021.
[2]	黄亚芳, 郭翔宇, 杜娟, 等. 社区中老年高血压用药患者单纯采用中药治疗的影响因素研究[J]. 中华全科医学, 2022, 20(12): 2075-2079. doi: 10.16766/j.cnki.issn.1674-4152.002773 HUANG Y F, GUO X Y, DU J, et al. Study on the influence factors of traditional Chinese medicine treatment in elderly patients with hypertension[J]. Chinese Journal of General Medicine, 2022, 20(12): 2075-2079. doi: 10.16766/j.cnki.issn.1674-4152.002773
[3]	张希惠, 王飞, 丁文波, 等. 半夏白术天麻汤对原发性高血压痰浊中阻证患者左心室能量损耗的影响[J]. 中国中医药信息杂志, 2023, 30(11): 162-166. ZHANG X H, WANG F, DING W B, et al. Effect of Banxia Baizhu Tianma Decoction on left ventricular energy loss in patients with essential hypertension with turbidity-blocking syndrome[J]. Chinese Information Journal of Traditional Chinese Medicine, 2023, 30(11): 162-166.
[4]	郑晓萍, 林莘, 陈惠. 铜砭刮痧疗法对肝阳上亢型高血压病的疗效及血管内皮功能的影响[J]. 光明中医, 2023, 38(7): 1390-1393. ZHENG X P, LIN X, CHEN H. Effect of Tongbian Gua Sha therapy on hypertension with liver-yang hyperactivity and vascular endothelial function[J]. Guangming Chinese Medicine, 2023, 38(7): 1390-1393.
[5]	中国高血压防治指南修订委员会, 高血压联盟, 中国医疗保健国际交流促进会高血压病学分会, 等. 中国高血压防治指南(2024年修订版)[J]. 中华高血压杂志(中英文), 2024, 32(7): 603-700. China Hypertension Prevention and Treatment Guidelines Revision Committee, Hypertension Alliance (China), China Association for the Promotion of International Exchanges in Health Care Hypertension Branch, etc. Chinese Guidelines for Prevention and Treatment of hypertension (2024 revision)[J]. Chinese Journal of Hypertension, 2024, 32(7): 603-700.
[6]	徐寒冰, 牛琳琳, 温鑫, 等. 针刺联合循经刮痧治疗原发性高血压的疗效观察及对24 h动态血压的影响[J]. 上海针灸杂志, 2023, 42(5): 459-465. XU H B, NIU L L, WEN X, et al. Therapeutic effect of acupuncture combined with Xunjing Gua Sha in treating essential hypertension[J]. Shanghai Journal of Acupuncture and Moxibustion, 2023, 42(5): 459-465.
[7]	王萍萍, 管日军. 半夏白术天麻汤联合氟桂利嗪对脑动脉供血不足导致眩晕患者症状及血流动力学的影响[J]. 实用中医内科杂志, 2022, 36(2): 115-117. WANG P P, GUAN R J. Effects of Banxia Baizhu Tianma Decoction combined with Flunarizine on symptoms and hemodynamics of vertigo patients with cerebral artery insufficiency[J]. Journal of Applied Chinese Medicine Internal Medicine, 2022, 36(2): 115-117.
[8]	成莎, 叶穗林, 叶玺. 温胆汤联合半夏白术天麻汤治疗原发性高血压合并高脂血症的临床疗效观察[J]. 中国实用医药, 2021, 16(26): 169-171. CHENG S, YE H L, YE X. Clinical effect of Wendan Decoction combined with Banxia Baizhu Tianma Decoction on primary hypertension complicated with hyperlipidemia[J]. Chinese Journal of Practical Medicine, 2021, 16(26): 169-171.
[9]	刘潇聪, 张玉苗, 潘亚磊. 天麻素药理作用及临床应用研究进展[J]. 中南药学, 2024, 22(6): 1615-1620. LIU X C, ZHANG Y M, PAN Y L. Research progress on pharmacological effects and clinical application of gastrodin[J]. Central South Pharmacy, 2024, 22(6): 1615-1620.
[10]	黄哲女, 谢思维, 刘芳, 等. 天麻素治疗高血压病的临床和作用机制研究进展[J]. 中国中医药科技, 2023, 30(2): 413-415. HUANG Z N, XIE S W, LIU F, et al. Research progress of gastrodin in the treatment of hypertension and its mechanism of action[J]. Chinese Journal of Chinese Medicine Science and Technology, 2023, 30(2): 413-415.
[11]	潘艳, 赵小芳, 成秀梅. 基于网络药理学探讨赤芍治疗肺动脉高压的活性成分及作用机制[J]. 基层医学论坛, 2023, 27(19): 1-3. PAN Y, ZHAO X F, CHENG X M. Study on the active ingredients and mechanism of action of Paeony in treating pulmonary hypertension based on network pharmacology[J]. Primary Medicine Forum, 2023, 27(19): 1-3.
[12]	王媚, 乔安平, 贾小刚, 等. 基于网络药理学和分子对接技术的天麻-川芎药对治疗高血压作用机制研究[J]. 天然产物研究与开发, 2022, 34(3): 473-483. WANG M, QIAO A P, JIA X G, et al. Study on the mechanism of action of gastrodia-Chuanxiong in the treatment of hypertension based on network pharmacology and molecular docking technology[J]. Natural Products Research and Development, 2022, 34(3): 473-483.
[13]	甘青霞, 刘珊. 虎符铜砭刮痧联合耳穴压豆对高血压患者的应用研究[J]. 中国疗养医学, 2024, 33(11): 46-49. GAN Q X, LIU S. Application of Hufu Tongbian Guasha combined with auricular point pressure on patients with hypertension[J]. Chinese Journal of Convalescent Medicine, 2024, 33(11): 46-49.
[14]	凌显淳, 赵盈坤, 李玉豆, 等. 基于"营卫气逆乃合而为胀"理论探讨原发性高血压的辨治[J]. 中国中医基础医学杂志, 2025, 31(8): 1436-1438. LING X C, ZHAO Y K, LI Y D, et al. Pathogenesis and treatment of hypertension in Chinese medicine based on the theory of Ying Qi and Wei Qi[J]. Journal Of Basic Chinese Medicine, 2025, 31(8): 1436-1438.
[15]	李晓函, 路美娟, 徐强, 等. 中医外治法治疗高血压病的机制及临床研究近况[J]. 湖北中医杂志, 2023, 45(5): 60-63. LI X H, LU M J, XU Q, et al. The mechanism and clinical research of external treatment of hypertension[J]. Hubei Journal of Traditional Chinese Medicine, 2023, 45(5): 60-63.
[16]	耿晓桐, 刘琦, 花娇娇, 等. 半夏化学成分及药理作用研究进展[J]. 山西化工, 2023, 43(9): 53-54, 61. GENG X T, LIU Q, HUA J J, et al. Research progress on chemical constituents and pharmacological effects of Pinellia sinensis[J]. Shanxi Chemical Industry, 2023, 43(9): 53-54, 61.
[17]	卢丹, 王媛媛, 张宏方. 天麻有效成分分析及其抗心血管疾病药理作用研究进展[J]. 现代中西医结合杂志, 2023, 32(19): 2769-2774. LU D, WANG Y Y, ZHANG H F. Analysis of the active components of Gastrodia gastrodia and research progress of its pharmacological action against cardiovascular diseases[J]. Journal of Modern Integrated Chinese and Western Medicine, 2023, 32(19): 2769-2774.
[18]	李毅, 李风兰. 天麻素抗骨质疏松机制研究进展[J]. 山东医药, 2024, 64(20): 107-111. LI Y, LI F L. Research progress on the anti-osteoporosis mechanism of gastrodin[J]. Shandong Medical Journal, 2024, 64(20): 107-111.
[19]	张楠, 陶源, 李春燕, 等. 白术的化学成分及药理作用研究进展[J]. 新乡医学院学报, 2023, 40(6): 579-586. ZHANG N, TAO Y, LI C Y, et al. Research progress on chemical constituents and pharmacological effects of Rhizoma albus[J]. Journal of Xinxiang Medical College, 2023, 40(6): 579-586.
[20]	周雪儿. 芍药苷的药理作用研究进展[J]. 临床医学进展, 2023, 13(11): 17341-17348. ZHOU X E. Research progress on the pharmacological effects of paeoniflorin[J]. Advances in Clinical Medicine, 2023, 13(11): 17341-17348.